カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の患者向け制御注射器市場2022年：電子インジェクター、機械式インジェクター、その他

◆英語タイトル：Global Patient Controlled Injectors Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8264 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：94 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

患者向け制御注射器市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の患者向け制御注射器の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

患者向け制御注射器市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・電子インジェクター、機械式インジェクター、その他

用途別セグメントは次のように区分されます。
・がん治療、自己免疫治療、造血系疾患治療、その他

世界の患者向け制御注射器市場の主要な市場プレーヤーは以下のとおりです。
・West Pharmaceutical Services, Inc.、Unilife Corporation、Sensile Medical、Roche、Janssen Pharmaceutical (Johnson & Johnson)、Westbourne Medical Ltd.

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、患者向け制御注射器製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な患者向け制御注射器メーカーの企業概要、2019年～2022年までの患者向け制御注射器の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な患者向け制御注射器メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別患者向け制御注射器の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの患者向け制御注射器の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での患者向け制御注射器市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および患者向け制御注射器の産業チェーンを掲載しています。
・第13、14、15章では、患者向け制御注射器の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：West Pharmaceutical Services, Inc.、Unilife Corporation、Sensile Medical、Roche、Janssen Pharmaceutical (Johnson & Johnson)、Westbourne Medical Ltd.
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：電子インジェクター、機械式インジェクター、その他
・用途別分析2017年-2028年：がん治療、自己免疫治療、造血系疾患治療、その他
・患者向け制御注射器の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・患者向け制御注射器のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・患者向け制御注射器のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・患者向け制御注射器の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・患者向け制御注射器の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Patient Controlled Injectors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Patient Controlled Injectors market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Cancer Treatment accounting for % of the Patient Controlled Injectors global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Electronical Injectors segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Patient Controlled Injectors include West Pharmaceutical Services, Inc., Unilife Corporation, Sensile Medical, Roche, and Janssen Pharmaceutical (Johnson & Johnson), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Patient Controlled Injectors market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Electronical Injectors
Mechanical Injectors
Others
Market segment by Application can be divided into
Cancer Treatment
Auto-immune Treatment
Blood Disorders Treatment
Others
The key market players for global Patient Controlled Injectors market are listed below:
West Pharmaceutical Services, Inc.
Unilife Corporation
Sensile Medical
Roche
Janssen Pharmaceutical (Johnson & Johnson)
Westbourne Medical Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Patient Controlled Injectors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Patient Controlled Injectors, with price, sales, revenue and global market share of Patient Controlled Injectors from 2019 to 2022.
Chapter 3, the Patient Controlled Injectors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Patient Controlled Injectors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Patient Controlled Injectors market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Patient Controlled Injectors.
Chapter 13, 14, and 15, to describe Patient Controlled Injectors sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Patient Controlled Injectors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Patient Controlled Injectors Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Electronical Injectors
1.2.3 Mechanical Injectors
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Patient Controlled Injectors Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cancer Treatment
1.3.3 Auto-immune Treatment
1.3.4 Blood Disorders Treatment
1.3.5 Others
1.4 Global Patient Controlled Injectors Market Size & Forecast
1.4.1 Global Patient Controlled Injectors Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Patient Controlled Injectors Sales in Volume (2017-2028)
1.4.3 Global Patient Controlled Injectors Price (2017-2028)
1.5 Global Patient Controlled Injectors Production Capacity Analysis
1.5.1 Global Patient Controlled Injectors Total Production Capacity (2017-2028)
1.5.2 Global Patient Controlled Injectors Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Patient Controlled Injectors Market Drivers
1.6.2 Patient Controlled Injectors Market Restraints
1.6.3 Patient Controlled Injectors Trends Analysis
2 Manufacturers Profiles
2.1 West Pharmaceutical Services, Inc.
2.1.1 West Pharmaceutical Services, Inc. Details
2.1.2 West Pharmaceutical Services, Inc. Major Business
2.1.3 West Pharmaceutical Services, Inc. Patient Controlled Injectors Product and Services
2.1.4 West Pharmaceutical Services, Inc. Patient Controlled Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Unilife Corporation
2.2.1 Unilife Corporation Details
2.2.2 Unilife Corporation Major Business
2.2.3 Unilife Corporation Patient Controlled Injectors Product and Services
2.2.4 Unilife Corporation Patient Controlled Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sensile Medical
2.3.1 Sensile Medical Details
2.3.2 Sensile Medical Major Business
2.3.3 Sensile Medical Patient Controlled Injectors Product and Services
2.3.4 Sensile Medical Patient Controlled Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Patient Controlled Injectors Product and Services
2.4.4 Roche Patient Controlled Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Janssen Pharmaceutical (Johnson & Johnson)
2.5.1 Janssen Pharmaceutical (Johnson & Johnson) Details
2.5.2 Janssen Pharmaceutical (Johnson & Johnson) Major Business
2.5.3 Janssen Pharmaceutical (Johnson & Johnson) Patient Controlled Injectors Product and Services
2.5.4 Janssen Pharmaceutical (Johnson & Johnson) Patient Controlled Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Westbourne Medical Ltd.
2.6.1 Westbourne Medical Ltd. Details
2.6.2 Westbourne Medical Ltd. Major Business
2.6.3 Westbourne Medical Ltd. Patient Controlled Injectors Product and Services
2.6.4 Westbourne Medical Ltd. Patient Controlled Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Patient Controlled Injectors Breakdown Data by Manufacturer
3.1 Global Patient Controlled Injectors Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Patient Controlled Injectors Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Patient Controlled Injectors
3.4 Market Concentration Rate
3.4.1 Top 3 Patient Controlled Injectors Manufacturer Market Share in 2021
3.4.2 Top 6 Patient Controlled Injectors Manufacturer Market Share in 2021
3.5 Global Patient Controlled Injectors Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Patient Controlled Injectors Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Patient Controlled Injectors Market Size by Region
4.1.1 Global Patient Controlled Injectors Sales in Volume by Region (2017-2028)
4.1.2 Global Patient Controlled Injectors Revenue by Region (2017-2028)
4.2 North America Patient Controlled Injectors Revenue (2017-2028)
4.3 Europe Patient Controlled Injectors Revenue (2017-2028)
4.4 Asia-Pacific Patient Controlled Injectors Revenue (2017-2028)
4.5 South America Patient Controlled Injectors Revenue (2017-2028)
4.6 Middle East and Africa Patient Controlled Injectors Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Patient Controlled Injectors Sales in Volume by Type (2017-2028)
5.2 Global Patient Controlled Injectors Revenue by Type (2017-2028)
5.3 Global Patient Controlled Injectors Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Patient Controlled Injectors Sales in Volume by Application (2017-2028)
6.2 Global Patient Controlled Injectors Revenue by Application (2017-2028)
6.3 Global Patient Controlled Injectors Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Patient Controlled Injectors Sales by Type (2017-2028)
7.2 North America Patient Controlled Injectors Sales by Application (2017-2028)
7.3 North America Patient Controlled Injectors Market Size by Country
7.3.1 North America Patient Controlled Injectors Sales in Volume by Country (2017-2028)
7.3.2 North America Patient Controlled Injectors Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Patient Controlled Injectors Sales by Type (2017-2028)
8.2 Europe Patient Controlled Injectors Sales by Application (2017-2028)
8.3 Europe Patient Controlled Injectors Market Size by Country
8.3.1 Europe Patient Controlled Injectors Sales in Volume by Country (2017-2028)
8.3.2 Europe Patient Controlled Injectors Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Patient Controlled Injectors Sales by Type (2017-2028)
9.2 Asia-Pacific Patient Controlled Injectors Sales by Application (2017-2028)
9.3 Asia-Pacific Patient Controlled Injectors Market Size by Region
9.3.1 Asia-Pacific Patient Controlled Injectors Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Patient Controlled Injectors Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Patient Controlled Injectors Sales by Type (2017-2028)
10.2 South America Patient Controlled Injectors Sales by Application (2017-2028)
10.3 South America Patient Controlled Injectors Market Size by Country
10.3.1 South America Patient Controlled Injectors Sales in Volume by Country (2017-2028)
10.3.2 South America Patient Controlled Injectors Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Patient Controlled Injectors Sales by Type (2017-2028)
11.2 Middle East & Africa Patient Controlled Injectors Sales by Application (2017-2028)
11.3 Middle East & Africa Patient Controlled Injectors Market Size by Country
11.3.1 Middle East & Africa Patient Controlled Injectors Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Patient Controlled Injectors Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Patient Controlled Injectors and Key Manufacturers
12.2 Manufacturing Costs Percentage of Patient Controlled Injectors
12.3 Patient Controlled Injectors Production Process
12.4 Patient Controlled Injectors Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Patient Controlled Injectors Typical Distributors
13.3 Patient Controlled Injectors Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Patient Controlled Injectors Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Patient Controlled Injectors Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. West Pharmaceutical Services, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. West Pharmaceutical Services, Inc. Major Business
Table 5. West Pharmaceutical Services, Inc. Patient Controlled Injectors Product and Services
Table 6. West Pharmaceutical Services, Inc. Patient Controlled Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Unilife Corporation Basic Information, Manufacturing Base and Competitors
Table 8. Unilife Corporation Major Business
Table 9. Unilife Corporation Patient Controlled Injectors Product and Services
Table 10. Unilife Corporation Patient Controlled Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sensile Medical Basic Information, Manufacturing Base and Competitors
Table 12. Sensile Medical Major Business
Table 13. Sensile Medical Patient Controlled Injectors Product and Services
Table 14. Sensile Medical Patient Controlled Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Roche Basic Information, Manufacturing Base and Competitors
Table 16. Roche Major Business
Table 17. Roche Patient Controlled Injectors Product and Services
Table 18. Roche Patient Controlled Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Janssen Pharmaceutical (Johnson & Johnson) Basic Information, Manufacturing Base and Competitors
Table 20. Janssen Pharmaceutical (Johnson & Johnson) Major Business
Table 21. Janssen Pharmaceutical (Johnson & Johnson) Patient Controlled Injectors Product and Services
Table 22. Janssen Pharmaceutical (Johnson & Johnson) Patient Controlled Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Westbourne Medical Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Westbourne Medical Ltd. Major Business
Table 25. Westbourne Medical Ltd. Patient Controlled Injectors Product and Services
Table 26. Westbourne Medical Ltd. Patient Controlled Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Patient Controlled Injectors Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 28. Global Patient Controlled Injectors Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Patient Controlled Injectors, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Patient Controlled Injectors Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Patient Controlled Injectors Production Site of Key Manufacturer
Table 32. Patient Controlled Injectors New Entrant and Capacity Expansion Plans
Table 33. Patient Controlled Injectors Mergers & Acquisitions in the Past Five Years
Table 34. Global Patient Controlled Injectors Sales by Region (2017-2022) & (K Units)
Table 35. Global Patient Controlled Injectors Sales by Region (2023-2028) & (K Units)
Table 36. Global Patient Controlled Injectors Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Patient Controlled Injectors Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Patient Controlled Injectors Sales by Type (2017-2022) & (K Units)
Table 39. Global Patient Controlled Injectors Sales by Type (2023-2028) & (K Units)
Table 40. Global Patient Controlled Injectors Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Patient Controlled Injectors Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Patient Controlled Injectors Price by Type (2017-2022) & (US$/Unit)
Table 43. Global Patient Controlled Injectors Price by Type (2023-2028) & (US$/Unit)
Table 44. Global Patient Controlled Injectors Sales by Application (2017-2022) & (K Units)
Table 45. Global Patient Controlled Injectors Sales by Application (2023-2028) & (K Units)
Table 46. Global Patient Controlled Injectors Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Patient Controlled Injectors Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Patient Controlled Injectors Price by Application (2017-2022) & (US$/Unit)
Table 49. Global Patient Controlled Injectors Price by Application (2023-2028) & (US$/Unit)
Table 50. North America Patient Controlled Injectors Sales by Country (2017-2022) & (K Units)
Table 51. North America Patient Controlled Injectors Sales by Country (2023-2028) & (K Units)
Table 52. North America Patient Controlled Injectors Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Patient Controlled Injectors Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Patient Controlled Injectors Sales by Type (2017-2022) & (K Units)
Table 55. North America Patient Controlled Injectors Sales by Type (2023-2028) & (K Units)
Table 56. North America Patient Controlled Injectors Sales by Application (2017-2022) & (K Units)
Table 57. North America Patient Controlled Injectors Sales by Application (2023-2028) & (K Units)
Table 58. Europe Patient Controlled Injectors Sales by Country (2017-2022) & (K Units)
Table 59. Europe Patient Controlled Injectors Sales by Country (2023-2028) & (K Units)
Table 60. Europe Patient Controlled Injectors Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Patient Controlled Injectors Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Patient Controlled Injectors Sales by Type (2017-2022) & (K Units)
Table 63. Europe Patient Controlled Injectors Sales by Type (2023-2028) & (K Units)
Table 64. Europe Patient Controlled Injectors Sales by Application (2017-2022) & (K Units)
Table 65. Europe Patient Controlled Injectors Sales by Application (2023-2028) & (K Units)
Table 66. Asia-Pacific Patient Controlled Injectors Sales by Region (2017-2022) & (K Units)
Table 67. Asia-Pacific Patient Controlled Injectors Sales by Region (2023-2028) & (K Units)
Table 68. Asia-Pacific Patient Controlled Injectors Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Patient Controlled Injectors Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Patient Controlled Injectors Sales by Type (2017-2022) & (K Units)
Table 71. Asia-Pacific Patient Controlled Injectors Sales by Type (2023-2028) & (K Units)
Table 72. Asia-Pacific Patient Controlled Injectors Sales by Application (2017-2022) & (K Units)
Table 73. Asia-Pacific Patient Controlled Injectors Sales by Application (2023-2028) & (K Units)
Table 74. South America Patient Controlled Injectors Sales by Country (2017-2022) & (K Units)
Table 75. South America Patient Controlled Injectors Sales by Country (2023-2028) & (K Units)
Table 76. South America Patient Controlled Injectors Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Patient Controlled Injectors Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Patient Controlled Injectors Sales by Type (2017-2022) & (K Units)
Table 79. South America Patient Controlled Injectors Sales by Type (2023-2028) & (K Units)
Table 80. South America Patient Controlled Injectors Sales by Application (2017-2022) & (K Units)
Table 81. South America Patient Controlled Injectors Sales by Application (2023-2028) & (K Units)
Table 82. Middle East & Africa Patient Controlled Injectors Sales by Region (2017-2022) & (K Units)
Table 83. Middle East & Africa Patient Controlled Injectors Sales by Region (2023-2028) & (K Units)
Table 84. Middle East & Africa Patient Controlled Injectors Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Patient Controlled Injectors Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Patient Controlled Injectors Sales by Type (2017-2022) & (K Units)
Table 87. Middle East & Africa Patient Controlled Injectors Sales by Type (2023-2028) & (K Units)
Table 88. Middle East & Africa Patient Controlled Injectors Sales by Application (2017-2022) & (K Units)
Table 89. Middle East & Africa Patient Controlled Injectors Sales by Application (2023-2028) & (K Units)
Table 90. Patient Controlled Injectors Raw Material
Table 91. Key Manufacturers of Patient Controlled Injectors Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Patient Controlled Injectors Typical Distributors
Table 95. Patient Controlled Injectors Typical Customers
List of Figures
Figure 1. Patient Controlled Injectors Picture
Figure 2. Global Patient Controlled Injectors Revenue Market Share by Type in 2021
Figure 3. Electronical Injectors
Figure 4. Mechanical Injectors
Figure 5. Others
Figure 6. Global Patient Controlled Injectors Revenue Market Share by Application in 2021
Figure 7. Cancer Treatment
Figure 8. Auto-immune Treatment
Figure 9. Blood Disorders Treatment
Figure 10. Others
Figure 11. Global Patient Controlled Injectors Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Patient Controlled Injectors Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Patient Controlled Injectors Sales (2017-2028) & (K Units)
Figure 14. Global Patient Controlled Injectors Price (2017-2028) & (US$/Unit)
Figure 15. Global Patient Controlled Injectors Production Capacity (2017-2028) & (K Units)
Figure 16. Global Patient Controlled Injectors Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Patient Controlled Injectors Market Drivers
Figure 18. Patient Controlled Injectors Market Restraints
Figure 19. Patient Controlled Injectors Market Trends
Figure 20. Global Patient Controlled Injectors Sales Market Share by Manufacturer in 2021
Figure 21. Global Patient Controlled Injectors Revenue Market Share by Manufacturer in 2021
Figure 22. Patient Controlled Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Patient Controlled Injectors Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Patient Controlled Injectors Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Patient Controlled Injectors Sales Market Share by Region (2017-2028)
Figure 26. Global Patient Controlled Injectors Revenue Market Share by Region (2017-2028)
Figure 27. North America Patient Controlled Injectors Revenue (2017-2028) & (USD Million)
Figure 28. Europe Patient Controlled Injectors Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Patient Controlled Injectors Revenue (2017-2028) & (USD Million)
Figure 30. South America Patient Controlled Injectors Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Patient Controlled Injectors Revenue (2017-2028) & (USD Million)
Figure 32. Global Patient Controlled Injectors Sales Market Share by Type (2017-2028)
Figure 33. Global Patient Controlled Injectors Revenue Market Share by Type (2017-2028)
Figure 34. Global Patient Controlled Injectors Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Patient Controlled Injectors Sales Market Share by Application (2017-2028)
Figure 36. Global Patient Controlled Injectors Revenue Market Share by Application (2017-2028)
Figure 37. Global Patient Controlled Injectors Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Patient Controlled Injectors Sales Market Share by Type (2017-2028)
Figure 39. North America Patient Controlled Injectors Sales Market Share by Application (2017-2028)
Figure 40. North America Patient Controlled Injectors Sales Market Share by Country (2017-2028)
Figure 41. North America Patient Controlled Injectors Revenue Market Share by Country (2017-2028)
Figure 42. United States Patient Controlled Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Patient Controlled Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Patient Controlled Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Patient Controlled Injectors Sales Market Share by Type (2017-2028)
Figure 46. Europe Patient Controlled Injectors Sales Market Share by Application (2017-2028)
Figure 47. Europe Patient Controlled Injectors Sales Market Share by Country (2017-2028)
Figure 48. Europe Patient Controlled Injectors Revenue Market Share by Country (2017-2028)
Figure 49. Germany Patient Controlled Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Patient Controlled Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Patient Controlled Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Patient Controlled Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Patient Controlled Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Patient Controlled Injectors Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Patient Controlled Injectors Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Patient Controlled Injectors Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Patient Controlled Injectors Revenue Market Share by Region (2017-2028)
Figure 58. China Patient Controlled Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Patient Controlled Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Patient Controlled Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Patient Controlled Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Patient Controlled Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Patient Controlled Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Patient Controlled Injectors Sales Market Share by Type (2017-2028)
Figure 65. South America Patient Controlled Injectors Sales Market Share by Application (2017-2028)
Figure 66. South America Patient Controlled Injectors Sales Market Share by Country (2017-2028)
Figure 67. South America Patient Controlled Injectors Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Patient Controlled Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Patient Controlled Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Patient Controlled Injectors Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Patient Controlled Injectors Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Patient Controlled Injectors Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Patient Controlled Injectors Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Patient Controlled Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Patient Controlled Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Patient Controlled Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Patient Controlled Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Patient Controlled Injectors in 2021
Figure 79. Manufacturing Process Analysis of Patient Controlled Injectors
Figure 80. Patient Controlled Injectors Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の患者向け制御注射器市場2022年：電子インジェクター、機械式インジェクター、その他(Global Patient Controlled Injectors Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の患者向け制御注射器市場2022年：電子インジェクター、機械式インジェクター、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp